Bafna Pharmaceuticals soars on clearing renewal of MHRA- UK audit process

03 Mar 2015 Evaluate

Bafna Pharmaceuticals is currently trading at Rs. 27.70, up by 0.95 points or 3.55% from its previous closing of Rs. 26.75 on the BSE.

The scrip opened at Rs. 27.70 and has touched a high and low of Rs. 28.35 and Rs. 26.90 respectively. So far 44887 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 38.50 on 02-Jul-2014 and a 52 week low of Rs. 16.90 on 01-Apr-2014.

Last one week high and low of the scrip stood at Rs. 29.00 and Rs. 24.10 respectively. The current market cap of the company is Rs. 51.86 crore.

The promoters holding in the company stood at 36.95% while Non-Institutions held 63.05% stake in the company.

Bafna Pharmaceuticals has successfully cleared the renewal of audit process as per the guidelines issued by the Medicine and Healthcare Product Agency (MHRA- UK) for European Union GMP.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

149.40 -3.00 (-1.97%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×